Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

503 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Potency and spectrum of tigecycline tested against an international collection of bacterial pathogens associated with skin and soft tissue infections (2000-2004).
Fritsche TR, Sader HS, Stilwell MG, Dowzicky MJ, Jones RN. Fritsche TR, et al. Among authors: sader hs. Diagn Microbiol Infect Dis. 2005 Jul;52(3):195-201. doi: 10.1016/j.diagmicrobio.2005.05.003. Diagn Microbiol Infect Dis. 2005. PMID: 16105564
In vitro activity of OPC-17116 compared to other broad-spectrum fluoroquinolones.
Sader HS, Erwin ME, Jones RN. Sader HS, et al. Eur J Clin Microbiol Infect Dis. 1992 Apr;11(4):372-81. doi: 10.1007/BF01962081. Eur J Clin Microbiol Infect Dis. 1992. PMID: 1327789
Antimicrobial activity of 11 newer and investigational drugs tested against aerobic isolates from spontaneous bacterial peritonitis.
Sader HS, Runyon BA, Erwin ME, Jones RN. Sader HS, et al. Diagn Microbiol Infect Dis. 1995 Feb;21(2):105-10. doi: 10.1016/0732-8893(94)00148-p. Diagn Microbiol Infect Dis. 1995. PMID: 7628189
Emerging multiply resistant enterococci among clinical isolates. I. Prevalence data from 97 medical center surveillance study in the United States. Enterococcus Study Group.
Jones RN, Sader HS, Erwin ME, Anderson SC. Jones RN, et al. Among authors: sader hs. Diagn Microbiol Infect Dis. 1995 Feb;21(2):85-93. doi: 10.1016/0732-8893(94)00147-o. Diagn Microbiol Infect Dis. 1995. PMID: 7628198
Prevalence of important pathogens and the antimicrobial activity of parenteral drugs at numerous medical centers in the United States. II. Study of the intra- and interlaboratory dissemination of extended-spectrum beta-lactamase-producing Enterobacteriaceae.
Sader HS, Pfaller MA, Jones RN. Sader HS, et al. Diagn Microbiol Infect Dis. 1994 Dec;20(4):203-8. doi: 10.1016/0732-8893(94)90004-3. Diagn Microbiol Infect Dis. 1994. PMID: 7705033
In vitro antimicrobial activity of cefpirome against ceftazidime-resistant isolates from two multicenter studies.
Sader HS, Jones RN. Sader HS, et al. Eur J Clin Microbiol Infect Dis. 1994 Aug;13(8):675-9. doi: 10.1007/BF01973999. Eur J Clin Microbiol Infect Dis. 1994. PMID: 7813503
Update of lomefloxacin in vitro activity and spectrum. A multicenter trial testing contemporary pathogens following Food and Drug Administration validation guidelines. Lomefloxacin Activity Study Group.
Jones RN, Sader HS, Erwin ME. Jones RN, et al. Among authors: sader hs. Diagn Microbiol Infect Dis. 1994 Oct;20(2):93-8. doi: 10.1016/0732-8893(94)90098-1. Diagn Microbiol Infect Dis. 1994. PMID: 7867311
In vitro activity of cefpodoxime compared with other oral cephalosporins tested against 5556 recent clinical isolates from five medical centers.
Sader HS, Jones RN, Washington JA, Murray PR, Gerlach EH, Allen SD, Erwin ME. Sader HS, et al. Diagn Microbiol Infect Dis. 1993 Aug-Sep;17(2):143-50. doi: 10.1016/0732-8893(93)90025-3. Diagn Microbiol Infect Dis. 1993. PMID: 8243035
Antimicrobial activity of the new carbapenem biapenem compared to imipenem, meropenem and other broad-spectrum beta-lactam drugs.
Sader HS, Jones RN. Sader HS, et al. Eur J Clin Microbiol Infect Dis. 1993 May;12(5):384-91. doi: 10.1007/BF01964439. Eur J Clin Microbiol Infect Dis. 1993. PMID: 8354307
Epidemiologic typing of multiply drug-resistant Pseudomonas aeruginosa isolated from an outbreak in an intensive care unit.
Sader HS, Pignatari AC, Leme IL, Burattini MN, Tancresi R, Hollis RJ, Jones RN. Sader HS, et al. Diagn Microbiol Infect Dis. 1993 Jul;17(1):13-8. doi: 10.1016/0732-8893(93)90063-d. Diagn Microbiol Infect Dis. 1993. PMID: 8359000
503 results
Jump to page
Feedback